Please assess the completion status of the following clinical trial:

Trial Title: Management of Severe Acute Malnutrition in SCD, in Northern Nigeria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* confirmed diagnoses of SCA, comparison children without SCD~* severe malnutrition defined as a BMI z-score \< -3~* age between 5 and 12 years (assessment can take place up until the 13th birthday)~* pass the appetite test~* uncomplicated malnutrition (good appetite, alert, no signs of infection of respiratory distress)~Exclusion Criteria:~* children with complicated severe acute malnutrition~* children with electrolyte disturbances (serum Na, K, PO4) at baseline~* children on disease-modifying therapy (hydroxyurea or regular blood transfusion therapy)~* children enrolled in other studies~* children with diabetes and other chronic illnesses~* children with known HIV infection~* children with a known allergy to dairy or peanuts.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- SCD - Ready-to-use therapeutic food and Hydroxyurea (Type: EXPERIMENTAL): 50-75 children (5-12 years old) with SCA and severe malnutrition will be randomly allocated to receive ready-to-use therapeutic food and hydroxyurea (20mg/kg/day)
- SCD - Ready-to-use therapeutic food alone (Type: PLACEBO_COMPARATOR): 50-75 children (5-12 years old) with SCA and severe malnutrition will be randomly allocated to receive ready-to-use therapeutic food alone
- Non-SCD siblings with severe malnutrition (Type: PLACEBO_COMPARATOR): To decrease the likelihood of sharing limited food resources, we will enroll up to 100 malnourished non-SCD siblings.

Based on this trial design, predict the completion outcome and termination type (if applicable).